Anticoagulation management of patients with long-term warfarin therapy after valve replacement during the perioperative period of pacemaker implantation.

Zhi-Hong Han, Xuejun Ren, Ye WangPubMed 2013

Abstract

The results showed that there was no significant difference in hematoma rate among continued group, discontinued group, and bridging group, but there was much more wound errhysis in the bridging group. Also, the study shows that if warfarin is continued, it will not increase the risk of bleeding when the International Normalized Ratio (INR) is around 1.7 during the procedure.
BibTeX
@inproceedings{han2013anticoagulation,
  author = {Zhi-Hong Han and Xuejun Ren and Ye Wang},
  title = {{Anticoagulation management of patients with long-term warfarin therapy after valve replacement during the perioperative period of pacemaker implantation.}},
  booktitle = {PubMed},
  year = {2013},
}

Loading related content...

Figure